Education
About Us
Working with TipRanks
Follow Us
Charles River Laboratories Intl (CRL)
NYSE:CRL
CRL Analyst Ratings
Hold
0 Buy
14 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CRL Stock 12 Month Forecast
Average Price Target
$159.00
▲(59.40% Upside)
| Highest Price Target$188.00 | Average Price Target$159.00 | Lowest Price Target$101.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TD Cowen
Reiterated
04/14/25
Bank of America Securities
Reiterated
04/14/25
Robert W. Baird
Reiterated
04/11/25
Morgan Stanley
Reiterated
04/10/25
Barclays
Reiterated
04/10/25
Mizuho Securities
Reiterated
04/09/25
Goldman Sachs
Downgraded
03/21/25
Jefferies
Reiterated
03/20/25
Redburn Atlantic
Upgraded
03/03/25
Evercore ISI
$175
Hold
75.44%
Upside
Reiterated
02/24/25
Charles River Labs (CRL) Gets a Hold from Evercore ISI
J.P. Morgan
$175→$165
Hold
65.41%
Upside
Reiterated
02/20/25
J.P. Morgan Sticks to Their Hold Rating for Charles River Labs (CRL)
William Blair
―
Hold
―
Downgraded
01/22/25
Charles River downgraded to Market Perform from Outperform at William BlairCharles River downgraded to Market Perform from Outperform at William Blair
UBS
$250→$185
Hold
85.46%
Upside
Downgraded
01/17/25
Charles River downgraded to Neutral from Buy at UBSCharles River downgraded to Neutral from Buy at UBS
CLSA
$164
Sell
64.41%
Upside
Downgraded
11/18/24
CLSA downgrades Charles River Labs (CRL) to Underperform (4)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
Reiterated
04/14/25
Bank of America Securities
Reiterated
04/14/25
Robert W. Baird
Reiterated
04/11/25
Morgan Stanley
Reiterated
04/10/25
Barclays
Reiterated
04/10/25
Mizuho Securities
Reiterated
04/09/25
Goldman Sachs
Downgraded
03/21/25
Jefferies
Reiterated
03/20/25
Redburn Atlantic
Upgraded
03/03/25
Evercore ISI
$175
Hold
75.44%
Upside
Reiterated
02/24/25
Charles River Labs (CRL) Gets a Hold from Evercore ISI
J.P. Morgan
$175→$165
Hold
65.41%
Upside
Reiterated
02/20/25
J.P. Morgan Sticks to Their Hold Rating for Charles River Labs (CRL)
William Blair
―
Hold
―
Downgraded
01/22/25
Charles River downgraded to Market Perform from Outperform at William BlairCharles River downgraded to Market Perform from Outperform at William Blair
UBS
$250→$185
Hold
85.46%
Upside
Downgraded
01/17/25
Charles River downgraded to Neutral from Buy at UBSCharles River downgraded to Neutral from Buy at UBS
CLSA
$164
Sell
64.41%
Upside
Downgraded
11/18/24
CLSA downgrades Charles River Labs (CRL) to Underperform (4)
Best Analysts Covering Charles River Labs
Which Analyst Should I Follow If I Want to Buy CRL and Sell After:
1 Month
xxx
Success Rate
5/9 ratings generated profit
Average Return
+1.71%
assigned a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 55.56% of your transactions generating a profit, with an average return of +1.71% per trade.
3 Months
xxx
Success Rate
6/9 ratings generated profit
Average Return
+4.97%
assigned a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +4.97% per trade.
1 Year
Success Rate
2/9 ratings generated profit
Average Return
-10.02%
assigned a buy rating 8 months ago
Copying Justin Bowers's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -10.02% per trade.
2 Years
xxx
Success Rate
1/9 ratings generated profit
Average Return
-24.63%
assigned a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 11.11% of your transactions generating a profit, with an average return of -24.63% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CRL Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
0
0
0
0
0
Buy
2
3
1
1
0
Hold
15
21
23
26
23
Sell
5
3
1
1
0
Strong Sell
0
0
0
0
0
total
22
27
25
28
23
Each month's total comprises the sum of three months' worth of ratings.
CRL Financial Forecast
CRL Stock Forecast FAQ
What is CRL’s average 12-month price target, according to analysts?
Based on analyst ratings, Charles River Laboratories Intl’s 12-month average price target is $159.00.
What is CRL’s upside potential, based on the analysts’ average price target?
Charles River Laboratories Intl has 59.40% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CRL a Buy, Sell or Hold?
Charles River Laboratories Intl has a consensus rating of Hold which is based on 0 buy ratings, 14 hold ratings and 0 sell ratings.
What is Charles River Laboratories Intl’s price target?
The average price target for Charles River Laboratories Intl is $159.00. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $188.00 ,the lowest forecast is $101.00. The average price target represents 59.40% Increase from the current price of $99.75.
The highest analyst price target is $188.00 ,the lowest forecast is $101.00. The average price target represents 59.40% Increase from the current price of $99.75.
What do analysts say about Charles River Laboratories Intl?
Charles River Laboratories Intl’s analyst rating consensus is a Hold. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of CRL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.